Myopia is becoming more common, as knowledge on detection and management increase. When should you start myopia control? Here we present an overview of when you might start myopia management across the spectrum of patient presentations. Since every child and their family are unique, we also point you towards more information for each situation.
Most clinicians are aware of myopia risk factors such as family history and visual environment, but how about axial length? This article explores how we can use the current axial length value, change in axial length, axial length growth charts, and another metric, the axial-length-to-corneal-radius (AL/CR ratio), to predict risk of a child developing myopia.
The COVID-19 pandemic saw widespread home confinement, increased screen time in children with home-based learning, and decreased time spent outdoors. Several recent publications have explored the impact of this period of time on the incidence and progression of myopia, lifestyle behaviours, digital eye strain, myopia treatment efficacy and more. What should we now monitor and discuss with our young myopic patients in the post-COVID world?
How can we identify pseudomyopia? The IMI defines myopia as -0.50D or more when accommodation is relaxed. Yet recent data indicates that a quarter of 6-year-olds may present as myopic when they’re in fact exhibiting pseudomyopia. Explore more on this topic and how to relax accommodation for accurate refractions in children.
In 2021, the World Council of Optometry (WCO) passed a resolution that publicly declares support for myopia management as standard of care. Since then, CooperVision has supported the WCO to empower eye care professionals to put this into action, with a multilingual online resource launched and more being added throughout 2022. Explore and learn more here.